JGJean-Philippe Girard

Jean-Philippe Girard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jean-Philippe Girard has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Espen S. Baekkevold

    Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway

    2 shared publications
  • François Amalric

    Institut de Pharmacologie et de Biologie Structurale du CNRS, Toulouse, France

    2 shared publications
  • Per Brandtzaeg

    Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway

    2 shared publications
  • Guttorm Haraldsen

    Institute of Clinical Medicine University of Oslo Oslo Norway

    1 shared publication
  • Jacques Feliu

    Laboratoire de Biologie Vasculaire, Institut de Pharmacologie et de Biologie Structurale du Centre National de la Recherche Scientifique, 205 route de Narbonne, 31077 Toulouse, France; and ‡Laboratory for Immunohistochemistry and Immunopathology, Institute of Pathology, University of Oslo, The National Hospital, Rikshospitalet, Oslo N-0027, Norway

    1 shared publication
  • Takeshi Yamanaka

    Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway

    1 shared publication

Latest Publications

  • Heterogeneity of Endothelial Cells

    by Jean-Philippe Girard, Espen S. Baekkevold, Takeshi Yamanaka, Guttorm Haraldsen, Per Brandtzaeg, François Amalric


  • Open Access

    Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules

    by Jean-Philippe Girard, Espen S. Baekkevold, Jacques Feliu, Per Brandtzaeg, François Amalric

    High endothelial venules (HEV) are specialized postcapillary venules found in lymphoid organs and chronically inflamed tissues that support high levels of lymphocyte extravasation from the blood. One of the major characteristics of HEV endothelial cells (HEVEC) is their capacity to incorporate large amounts of sulfate into sialomucin-type counter-receptors for the lymphocyte homing receptor L-selectin. Here, we show that HEVEC express two functional classes of sulfate transporters defined by their differential sensitivity to the anion-exchanger inhibitor 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS), and we report the molecular characterization of a DIDS-resistant sulfate transporter from human HEVEC, designated SUT-1. SUT-1 belongs to the family of Na + -coupled anion transporters and exhibits 40–50% amino acid identity with the rat renal Na + /sulfate cotransporter, NaSi-1, as well as with the human and rat Na + /dicarboxylate cotransporters, NaDC-1/SDCT1 and NaDC-3/SDCT2. Functional expression studies in cRNA-injected Xenopus laevis oocytes showed that SUT-1 mediates high levels of Na + -dependent sulfate transport, which is resistant to DIDS inhibition. The SUT-1 gene mapped to human chromosome 7q33. Northern blotting analysis revealed that SUT-1 exhibits a highly restricted tissue distribution, with abundant expression in placenta. Reverse transcription–PCR analysis indicated that SUT-1 and the diastrophic dysplasia sulfate transporter (DTD), one of the two known human DIDS-sensitive sulfate transporters, are coexpressed in HEVEC. SUT-1 and DTD could correspond, respectively, to the DIDS-resistant and DIDS-sensitive components of sulfate uptake in HEVEC. Together, these results demonstrate that SUT-1 is a distinct human Na + -coupled sulfate transporter, likely to play a major role in sulfate incorporation in HEV.